2024 ICD-10-CM Diagnosis Code C62.9

Malignant neoplasm of testis, unspecified whether descended or undescended

C62.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
Short description: Malignant neoplasm of testis, unsp descended or undescended
The 2024 edition of ICD-10-CM C62.9 became effective on October 1, 2023.
This is the American ICD-10-CM version of C62.9 – other international versions of ICD-10 C62.9 may differ.

The following code(s) above C62.9 contain annotation back-references

that may be applicable to C62.9:

Clinical Information

A primary or metastatic malignant neoplasm involvingf the testis
Testicular cancer forms in a man’s testicles, the two egg-shaped glands that produce sperm and testosterone. Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who
- have had abnormal testicle development
- have had an undescended testicle
- have a family history of the cancer
symptoms include pain, swelling or lumps in your testicles or groin area. Most cases can be treated, especially if it is found early. Treatment options include surgery, radiation and/or chemotherapy. Regular exams after treatment are important. Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment. nih: national cancer institute

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change
2024 (effective 10/1/2023): No change

Code annotations containing back-references to C62.9:

Diagnosis Index entries containing back-references to C62.9: